JSPR Live signals | Maximize Profits with Getagraph.com

SELL 110988 min ago

@ $17.42

Issued: 9 Feb 2024 @ 13:49

Return: 17.12%

Previous signal: Feb 8 - 11:44

Previous signal: Buy

Return: 5.05 %

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies...

Stats
Today's Volume	52 191.00
Average Volume	115 967
Market Cap	307.75M
EPS	$0 ( 2024-03-13 )
Next earnings date	( $-1.200 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.330
ATR14	$0.101 (0.50%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-12	Mahal Jeetinder Singh	Buy	900	Voting Common Stock
2024-03-12	Mahal Jeetinder Singh	Sell	900	Voting Common Stock
2024-03-12	Mahal Jeetinder Singh	Buy	900	Stock Option (right to buy)
2024-02-15	Martell Ron	Buy	100 000	Stock Option (right to buy)
2024-02-15	Mahal Jeetinder Singh	Buy	40 000	Stock Option (right to buy)

INSIDER POWER
91.97
Last 82 transactions
Buy: 17 940 158 \| Sell: 1 631 987

Volume Correlation

Long: 0.16 (neutral)

Short: 0.79 (moderate)

Signal:(46.128) Neutral

Jasper Therapeutics, Inc. Correlation

10 Most Positive Correlations
SCR	0.947
PAIC	0.946
SRRA	0.928
SVAC	0.92
CMPO	0.915
ICON	0.912
TLGT	0.91
PAE	0.908
KIN	0.908
CRVL	0.907

10 Most Negative Correlations
NETE	-0.947
LCAP	-0.939
VTIP	-0.924
AMRB	-0.915
OP	-0.901
RAVN	-0.899
MMAC	-0.898
NAKD	-0.896
NRBO	-0.896
PCSA	-0.895

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Jasper Therapeutics, Inc. Correlation - Currency/Commodity

0.34
( neutral )

-0.64
( weak negative )

0.00
( neutral )

0.38
( neutral )

-0.41
( neutral )

-0.85
( strong negative )

Jasper Therapeutics, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-1.11M (0.00 %)
EPS:	$-6.18

FY	2023
Revenue:	$0
Gross Profit:	$-1.11M (0.00 %)
EPS:	$-6.18

FY	2022
Revenue:	$0
Gross Profit:	$-1.31M (0.00 %)
EPS:	$-6.63

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-2.69

Financial Reports:

No articles found.

Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.